March 23 (Reuters) – Gilead Sciences said on Monday it would buy privately held biotech firm Ouro Medicines in a deal worth up to $2.18 billion.
(Reporting by Mariam Sunny in Bengaluru; Editing by Shilpi Majumdar)
March 23 (Reuters) – Gilead Sciences said on Monday it would buy privately held biotech firm Ouro Medicines in a deal worth up to $2.18 billion.
(Reporting by Mariam Sunny in Bengaluru; Editing by Shilpi Majumdar)
NEW YORK (AP) — A jet landing at New York City’s LaGuardia Airport collided with a fire truck on the runway, killing the pilot and copilot and injuring several others.…
A bill introduced in the Senate on Monday would ban prediction markets like Kalshi and Polymarket from accepting or listing transactions related to sports events and casino-style games. The bill,…